Earnings Data
Report Date
Nov 04, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.91Last Year’s EPS
-0.3Same Quarter Last Year
Strong Buy
Based on 12 Analysts Ratings
DE:1S1 Q2 2026 Earnings Report
DE:1S1 Upcoming Earnings
Viridian Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
DE:1S1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:1S1 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2026 | €18.00 | €17.60 | -2.22% |
May 05, 2026 | €11.30 | €11.90 | +5.31% |
Feb 26, 2026 | €25.31 | €24.36 | -3.75% |
Nov 05, 2025 | €19.80 | €19.36 | -2.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Viridian Therapeutics (DE:1S1) report earnings?
Viridian Therapeutics (DE:1S1) is schdueled to report earning on Nov 04, 2026, TBA (Confirmed).
What is Viridian Therapeutics (DE:1S1) earnings time?
Viridian Therapeutics (DE:1S1) earnings time is at Nov 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Viridian Therapeutics stock?
The P/E ratio of Viridian Therapeutics is N/A.
What is DE:1S1 EPS forecast?
DE:1S1 EPS forecast for the fiscal quarter 2026 (Q3) is -0.91.